Therapy of chronic hepatitis C early on can prevent the progression toward hardening of the liver (cirrhosis) and liver cancer (hepatocellular carcinoma).
"Infection with hepatitis C can be treated and most curable. Results for a 10-year study showed early treatment may prevent cirrhosis and decreased risk of liver cancer and death. The cost of treatment also could be pressured," said Chairman of the Indonesian Heart Research Association (PPHI) Dr. Superior Budihusodo, SpPD, KGEH.
According to him, hepatitis C therapy is primarily intended to eliminate the virus, stop the progression of the disease and eliminate symptoms of the disease, among others, characterized by distended abdomen, swollen legs and body yellow.